Chike Onwuneme1,2,3, Alfonso Blanco2, Amanda O'Neill2, Bill Watson2, Eleanor J Molloy1,4,5,6,7. 1. Department of Neonatology, National Maternity Hospital, Dublin, Ireland. 2. University College Dublin School of Medicine and Medical Science, Conway Institute for Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland. 3. Department of Paediatrics, Children's University Hospital, Dublin, Ireland. 4. Department of Paediatrics, Royal College of Surgeons, Dublin, Ireland. 5. Department of Neonatology, Our Lady's Children's Hospital, Dublin, Ireland. 6. Department of Paediatrics, Trinity College Dublin, National Children's Hospital, Dublin, Ireland. 7. Department of Neonatology, Coombe Women's and Infants University Hospital, Dublin, Ireland.
Abstract
BACKGROUND: Newborn infants are endotoxin tolerant which may be responsible for their increased susceptibility to bacterial sepsis. Vitamin D has an immunomodulatory effect and newborn infants are at risk of vitamin D deficiency. We examined the in vitro effect of 1, 25-dihydroxyvitamin D (1,25OHD) on whole blood phagocytic toll-like receptor 4 (TLR4), CD11b, and reactive oxygen intermediates (ROIs) in newborn infants during sepsis. METHODS: Whole blood from preterm infants <32-wk gestation, control term neonates, and adults were sampled for phagocytic expression of ROI, TLR4, CD11b in response to lipopolysaccharide (LPS), and 1,25OHD using flow cytometer. RESULTS: ROI production from newborn phagocytes incubated with LPS alone was decreased. Pretreatment with 1,25OHD demonstrated increased (P = 0.001) phagocytic ROI production in newborns but not in adults. 1,25OHD did not have any effect on TLR4 and CD11b in both newborns and adults. Pretreatment with ROI inhibitors (apocynin (APO) and diphenyleneiodonium), phosphoinositide 3-kinase (PI3K) inhibitor, and p38 inhibitor blocked neutrophil ROI production. CONCLUSION: Neonatal phagocytic cells had diminished ROI production in the presence of LPS, however, pretreatment with 1,25OHD reversed this hyporesponsiveness. This action by 1,25OHD was mediated by activation of nicotinamide adenine dinucleotide phosphate oxidase system through PI3K signaling enzymes.
BACKGROUND: Newborn infants are endotoxin tolerant which may be responsible for their increased susceptibility to bacterial sepsis. Vitamin D has an immunomodulatory effect and newborn infants are at risk of vitamin D deficiency. We examined the in vitro effect of 1, 25-dihydroxyvitamin D (1,25OHD) on whole blood phagocytic toll-like receptor 4 (TLR4), CD11b, and reactive oxygen intermediates (ROIs) in newborn infants during sepsis. METHODS: Whole blood from preterm infants <32-wk gestation, control term neonates, and adults were sampled for phagocytic expression of ROI, TLR4, CD11b in response to lipopolysaccharide (LPS), and 1,25OHD using flow cytometer. RESULTS: ROI production from newborn phagocytes incubated with LPS alone was decreased. Pretreatment with 1,25OHD demonstrated increased (P = 0.001) phagocytic ROI production in newborns but not in adults. 1,25OHD did not have any effect on TLR4 and CD11b in both newborns and adults. Pretreatment with ROI inhibitors (apocynin (APO) and diphenyleneiodonium), phosphoinositide 3-kinase (PI3K) inhibitor, and p38 inhibitor blocked neutrophil ROI production. CONCLUSION: Neonatal phagocytic cells had diminished ROI production in the presence of LPS, however, pretreatment with 1,25OHD reversed this hyporesponsiveness. This action by 1,25OHD was mediated by activation of nicotinamide adenine dinucleotide phosphate oxidase system through PI3K signaling enzymes.
Authors: O Levy; S Martin; E Eichenwald; T Ganz; E Valore; S F Carroll; K Lee; D Goldmann; G M Thorne Journal: Pediatrics Date: 1999-12 Impact factor: 7.124
Authors: Olajumoke Akinsulire; George Perides; Lorenzo Anez-Bustillos; Joanne Cluette-Brown; Arthur Nedder; Elizabeth Pollack; Pratibha Singh; Yan Liu; Lady Leidy Sanchez-Fernandez; Evelyn Obregon; Ece Bicak; Savanna Kiefer; William Yakah; Hilda V Gutierrez; Duy T Dao; Mustafa Vurma; Stefan Ehling; Douglas Gordon; Stephen DeMichele; Steven D Freedman; Camilia R Martin Journal: JPEN J Parenter Enteral Nutr Date: 2019-08-23 Impact factor: 4.016
Authors: Maria Giulia Conti; Asimenia Angelidou; Joann Diray-Arce; Kinga K Smolen; Jessica Lasky-Su; Mario De Curtis; Ofer Levy Journal: Pediatr Res Date: 2019-11-05 Impact factor: 3.756